# MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)

> **NCT03880851** · NA · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 78 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Plan adaptation of Radiation Treatment in case of anatomical changes

## Key facts

- **NCT ID:** NCT03880851
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-23
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880851, "MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03880851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*